GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » Other Income (Expense)

Rayont (Rayont) Other Income (Expense) : $2.73 Mil (TTM As of Mar. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Rayont Other Income (Expense)?

Rayont's other income expense for the Rayont's pretax income for the three months ended in Mar. 2023 was $0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2023 was $2.73 Mil.


Rayont Other Income (Expense) Historical Data

The historical data trend for Rayont's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayont Other Income (Expense) Chart

Rayont Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Jun22
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.04 0.07 0.23 2.37

Rayont Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 1.86 0.87 - -

Rayont Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rayont  (OTCPK:RAYT) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Rayont (Rayont) Business Description

Traded in Other Exchanges
N/A
Address
228 Hamilton Avenue, 3rd Floor, Palo Alto, CA, USA, 94301
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Executives
Meng Leong Liew director 1313 N. GRAND AVE. #16, WALNUT CA 91789
Kha Foo Chin director, 10 percent owner, officer: President, Treasurer ROOM 1217 NORTH TOWER, CONORDIA PLAZA, NO 1 SCIENCE MUSEUM RD., TSIM SHA TSUI E, KOWLOON K3 NA